Evaluation of a standardized treatment regimen for acromegaly: A multi centre intervention study - Treatment for Acromegaly

Österreichisches Akromegalie Register0 个研究点开始时间: 2014年7月9日最近更新: 2014年8月11日

适应症

试验速览

暂无简介。

•1. All patients with diagnosed but untreated or inadequately treated acromegaly attending the study centres
•(specialized outpatient departments) in Austria will be asked to participate in this study. Patients will be included
•independent of previous treatments for acromegaly including surgery and/or radiation as well as no surgery due
•to patients wish or inoperability.
•2. Age =18 yrs.
•3. MRI of the Sellaregion not older than 6 months prior to study entry
•4. Written informed consent
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 60
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 40

•1. Patients on Pegvisomant at the time of inclusion
•2. Previous treatment or interruption of treatment with Pegvisomant due to lack of effect
•3. Known hypersensitivity or intolerance to Pegvisomant or the components of its pharmacological preparation
•4. Pregnancy or lactation
•5. Active liver disease (ASAT and ALAT >3x ULN)

发起方

Österreichisches Akromegalie Register